A. Sarkissian

Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity.

S. Forman, Christine E. Brown, D. Alizadeh, 2018, JCI insight.

Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma.

B. Badie, M. D'Apuzzo, S. Forman, 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma

Li Li, Yanhong Shi, B. Badie, 2020, Science Translational Medicine.

Chlorotoxin Redirects Chimeric Antigen Receptor T Cells for Specific and Effective Targeting of Glioblastoma

Yanhong Shi, B. Badie, S. Forman, 2020, bioRxiv.

The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma

Jinhui Wang, Xiwei Wu, Xiuli Wang, 2020, Cancer Immunology Research.

In vitro and in vivo chemosensitizing activity of LFM-A13, a dual-function inhibitor of Bruton's tyrosine kinase and polo-like kinases, against human leukemic B-cell precursors

F. Uckun, S. Qazi, I. Dibirdik, 2011, Arzneimittelforschung.